[Skip to the reading](#reading) A little clarity, from Summer. [Summer](/) [The guides](/#the-guides)[Your questions](/#the-goals)[About Summer](/about/) **Explore +** [The guides](/#the-guides)[Your questions](/#the-goals)[About Summer](/about/)[Common questions](/faq/)[The glossary](/glossary/)[Contact](/contact/) [Summer](/)/peptide references Read a little further # The reading shelf. These peptide references offer a few useful starting points. Each link has a particular job: a safety concern, an approval question or the limits of an ingredient’s research. [How Promise Peptides works↗](https://mypromise.com/products?utm_source=summer&utm_medium=affiliate&utm_campaign=references&utm_content=opening) Summer may earn money when readers become Promise patients. Promise Peptides prescribes now through licensed U.S. providers. A provider reviews each request and decides; not everyone qualifies. U.S. patients only. Availability varies by state and treatment. Compounded medicines are not FDA-approved. On this page - [Read with a question in mind.](#read-with-a-question) - [Approval and safety information.](#approval-and-safety) - [The research question.](#the-research-question) - [Bring the reading back to the question.](#bring-it-back-to-care) ## Read with a question in mind. A source is most useful when you know what it can answer. An FDA page can describe an approval or a safety concern. A clinical paper can report what happened in the people it studied. Neither turns every similarly named product into the same medicine. This is a small shelf, rather than a count of everything ever published. The compound guides carry their own focused links where a source helps the reader understand an important distinction. ## Approval and safety information. The FDA’s compounding safety page has separate tables. One is for ingredients in Category 2, a group with significant safety concerns. Another lists ingredients whose nominations were withdrawn. On the page current as of April 22, 2026, several familiar peptides appear in the withdrawn table. Withdrawal is not FDA clearance or approval. The safety concerns remain. Approved-product safety information for semaglutide and tirzepatide is another kind of source. It concerns particular approved medicines. Compounded semaglutide and compounded tirzepatide are not FDA-approved, and those labels do not establish the safety of every compounded preparation. ## The research question. The FDA’s BPC-157 review is useful for its examination of limited human evidence and its safety concerns. Its epitalon review helps separate that peptide from epithalamin, an older gland extract. The similar names are a reminder to check exactly what was tested. When reading any study, look for the population, the form of the ingredient, the comparison group and the outcome. A measurement in cells is not an outcome in a person. A trial finding is also not a prediction about one reader’s health. ## Bring the reading back to the question. A long reference list cannot replace a provider’s assessment. The point of reading is to understand the conversation, rather than to arrive with a prescription already decided. A licensed provider can weigh a person’s health history and explain why an option is inappropriate. The [writing and checking page](/method/) explains our approach to these distinctions. If a word stops the flow, the [glossary](/glossary/) is nearby. For questions about a Promise consultation, its own support is the right destination. ## Read a little further. - [FDA’s compounding safety page](https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks) - [Semaglutide product safety information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b) - [Tirzepatide product safety information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b) - [FDA’s BPC-157 review](https://www.fda.gov/media/193343/download) - [FDA’s epitalon review](https://www.fda.gov/media/193345/download) ## When a question needs a provider. A consultation is a place for a licensed review of your health. It can end without a prescription. There is room for that answer too. [How Promise Peptides works↗](https://mypromise.com/products?utm_source=summer&utm_medium=affiliate&utm_campaign=references&utm_content=closing) Summer may earn money when readers become Promise patients. Promise Peptides prescribes now through licensed U.S. providers. A provider reviews each request and decides; not everyone qualifies. U.S. patients only. Availability varies by state and treatment. Compounded medicines are not FDA-approved. [Summer](/) Room for the questions. Care with the answers. ## Start somewhere - [The compound guides](/#the-guides) - [The goal guides](/#the-goals) - [Common questions](/faq/) ## A little context - [About Summer](/about/) - [The glossary](/glossary/) - [How we write and check](/method/) ## Keep in touch - [The reading shelf](/references/) - [Contact](/contact/) - [Read in Markdown](/references/index.md) Summer may earn money when readers become Promise patients. Summer Peptides is an independent guide and is not Promise Peptides. Summer is a place to read and ask better questions; it offers no clinic, pharmacy or shop, and these pages cannot give personal medical advice. Promise Peptides prescribes now through licensed U.S. providers. A provider reviews each request and decides; not everyone qualifies. U.S. patients only. Availability varies by state and treatment. Compounded medicines are not FDA-approved. If a provider prescribes, a licensed U.S. compounding pharmacy separately decides whether it can lawfully prepare the prescription. Compounded medicines are not FDA-approved. Promise is LegitScript-certified; that certification is not FDA approval. © 2026 Summer Peptides [How Promise Peptides works](https://mypromise.com/products?utm_source=summer&utm_medium=affiliate&utm_campaign=references&utm_content=footer)